文献
J-GLOBAL ID:201802244108577161
整理番号:18A0403195
COPD患者におけるプロピオン酸ベクロメタゾン/ホルモテロールフマレートの2製剤の急性心血管系安全性:単回投与,無作為化,プラセボ対照交差試験【Powered by NICT】
Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study
著者 (6件):
Singh Dave
(University of Manchester, Medicines Evaluation Unit, The Langley Building, University Hospital of South Manchester, Southmoor Rd, Wythenshawe M23 9QZ, United Kingdom)
,
Ciurlia Giorgia
(Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy)
,
Piccinno Annalisa
(Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy)
,
Muraro Annamaria
(Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy)
,
Bocchi Maria
(Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy)
,
Scuri Mario
(Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy)
資料名:
Pulmonary Pharmacology & Therapeutics
(Pulmonary Pharmacology & Therapeutics)
巻:
42
ページ:
43-51
発行年:
2017年
JST資料番号:
T0708A
ISSN:
1094-5539
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)